A study of the cost analysis of various oral antihypertensive drugs available in Indian market

Simple item page
dc.contributor.authorArya, Neeleshen_US
dc.contributor.authorAgrawal, Shwetaen_US
dc.contributor.authorAgrawal, Mehulen_US
dc.date.accessioned2020-04-23T07:57:35Z
dc.date.available2020-04-23T07:57:35Z
dc.date.issued2019-08
dc.description.abstractBackground: Hypertension is a serious global public health problem. It accounts for 10% of all deaths in India and is the leading non-communicable disease. Recent studies have shown that the prevalence of hypertension is 25% in urban and 10% in rural people in India. It exerts a substantial public health burden on cardiovascular health status and health care systems in India. Antihypertensive treatment effectively reduces hypertension related morbidity and mortality. The cost of medications has always been a barrier to effective treatment. The increasing prevalence of hypertension requires use of cost effective treatment for the effective management of the disease.Methods: Cost of a particular drug (cost per 10 tablets) in the same strength and dosage forms being manufactured by different companies was obtained from Current Index of Medical Specialties, Jan?April 2019 and “Indian Drug Review” (IDR) September 2018. Difference between the maximum and minimum cost of the same drug manufactured by different pharmaceutical companies was calculated and percentage cost variation was calculated.Results: The prices of a total of 24 drugs (15 single and 9 combination preparations), available in 59 different formulations were analysed. These 62 formulations are manufactured by different pharmaceutical companies.Conclusions: The average percentage price variation of different brands of the same oral antihypertensive drug manufactured in India is very wide. The appraisal and management of marketing drugs should be directed toward maximizing the benefits of therapy and minimizing negative personal and economic consequences.en_US
dc.identifier.affiliationsDepartment of Pharmacology, Gandhi Medical college, Bhopal, Madhya Pradesh, Indiaen_US
dc.identifier.affiliationsDepartment of Shalakya Tantra, Pt. K.L.S. Govt. (Auto.) Ayurvedic College and Hospital, Bhopal, Madhya Pradesh, Indiaen_US
dc.identifier.citationArya Neelesh, Agrawal Shweta, Agrawal Mehul. A study of the cost analysis of various oral antihypertensive drugs available in Indian market. International Journal of Basic & Clinical Pharmacology. 2019 Aug; 8(8): 1850-1854en_US
dc.identifier.issn2319-2003
dc.identifier.issn2279-0780
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/200294
dc.languageenen_US
dc.publisherMedip Academyen_US
dc.relation.issuenumber8en_US
dc.relation.volume8en_US
dc.source.urihttps://dx.doi.org/10.18203/2319-2003.ijbcp20193205en_US
dc.subjectAntihypertensive drugsen_US
dc.subjectCost analysisen_US
dc.subjectHypertensionen_US
dc.subjectPharmacoeconomicsen_US
dc.titleA study of the cost analysis of various oral antihypertensive drugs available in Indian marketen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
ijbcp2019v8n8p1850.pdf
Size:
248.88 KB
Format:
Adobe Portable Document Format
Download
Collections
International Journal of Basic & Clinical Pharmacology